Clinical Oncology – Year 2017 In Review

The clinical practice of oncology is a rapidly-evolving discipline. This program will provide physicians – especially oncologists, hematologists, urologists, gastroenterologists, gynecologists, and pulmonologists -- as well as pharmacists, nurse practitioners and physician assistants, with a summary of the latest advances in discipline-related cancers. New therapeutic agents will be a topic of discussion. This program will focus on how these new advances will impact the practice of oncology today.

Educational Objectives

  • Examine the changes being adapted in the clinical management of lymphoma.
  • Discuss recent clinical studies evaluating the activity of checkpoint inhibitors in solid tumor malignancies, including breast, GU, GI, lung, sarcoma, gynecological cancers, H&N cancer and melanoma.
  • Appraise potential of novel agents and drug combinations in the early clinical trials.
  • Recognize important toxicities associated with immune checkpoint inhibitors and their management.
  • Develop an understanding of the importance of clinical trials in the development of novel anti-cancer modalities and combinations, and the use of correlative studies in their development.

Dates: Saturday, August 26, 2017 

Location: Roswell Park Cancer Institute, Elm & Carlton Sts. Buffalo, NY 14263

Register Now


Roswell Park Cancer Institute is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. Roswell Park Cancer Institute designates this live educational activity for a maximum of 7.25 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. This education activity will be submitted to the American Association of Nurse Practitioners for approval up to 7.25 contact hours of accredited education.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Clinical Oncology-Year 2017 in Review is a knowledge-based activity and will award up to 7.17 contact hours of continuing pharmacy education credit. Please note sessions have been individually accredited for this activity. Continuing education credit will be uploaded to the CPE Monitor based on the individual sessions attended and completion of the CE attendance form.

This education activity will be submitted to the American Association of Nurse Practitioners for approval of up to 7.25 contact hours of accredited education.

Registration Fees

$75 - Physicians
$50 - Pharmacists
$35 - NPs, PAs, other healthcare professionals
Free - Residents, Fellows, Students, Retired Physicians
$250 - Pharmaceutical Industry Employees

Cancellation Policy

Roswell Park Cancer Institute reserves the right to cancel this program for any reason. Requests for refunds must be in writing. No refunds will be issued for cancellations received after August 21, 2017. 

Agenda & Speakers

7:15 – 8 a.m.
Registration and Breakfast

8 a.m. 
Welcome and Opening Remarks
Marc Ernstoff, MD and Igor Puzanov, MD, MSCI, FACP

8:05 a.m. 
Update on Lymphoma 
Nishitha Reddy, MBBS, MSCI

8:45 a.m.
GU: Prostate/Bladder and Renal Cancer
Gurkamal Chatta, MD

9:30 a.m.
Lung Cancer
Grace Dy, MD

10:15 a.m.

10:45 a.m.
Anne Grand’Maison, MD

11:30 a.m.
Head & Neck Cancer
Conor Steuer, MD

12:15 p.m.

1:15 p.m.
Breast Cancer
Mateusz Opyrchal, MD, PhD

2 p.m.
Marc Ernstoff, MD

2:45 p.m.
GI: Colon, Esophageal, Liver, Pancreas Cancer
Patrick Boland, MD

3:30 p.m.

3:45 p.m.
T-Cell Therapy 
Richard Koya, MD, PhD

4:30 p.m.
New Drugs in Development
Igor Puzanov, MD, MSCI, FACP

5 p.m.
Closing Remarks
Marc Ernstoff, MD and Igor Puzanov, MD, MSCI, FACP

5:15 p.m.

Invited Speakers

Nishitha Reddy, MBBS, MSCI
Associate Professor of Medicine
Vanderbilt-Ingram Cancer Center
Nashville, TN

Conor Steuer, MD
Assistant Professor
Department of Hematology and Medical Oncology
Emory University School of Medicine
Atlanta, GA

Roswell Park Faculty

Patrick Boland, MD
Assistant Professor of Oncology
Department of Medicine, GI Center

Gurkamal Chatta, MD
Professor of Oncology
Clinical Chief of Genitourinary Medicine

Grace Dy, MD
Associate Professor of Oncology
Department of Medicine
Division Chief, Thoracic Oncology

Marc Ernstoff, MD
Professor & Chair Department of Medicine
Senior Vice President for Clinical Investigation
The Katherine Anne Gioia Chair of Medicine

Anne Grand’Maison, MD
Assistant Professor of Oncology
Director, Sarcoma Medical Oncology

Richard Koya, MD, PhD
Associate Professor of Oncology
Associate Director, Center of Immunotherapy
Director, Vector Development & Production Facility

Mateusz Opyrchal, MD, PhD
Assistant Professor of Oncology
Department of Medicine

Igor Puzanov, MD, MSCI, FACP
Professor of Oncology
Department of Medicine
Chief, Melanoma Section
Director, Early Phase Clinical Trials
Program Co-Leader, CCSG Experimental Therapeutics Program


A block of rooms has been reserved at the DoubleTree Buffalo Downtown, which is adjacent to Roswell Park Cancer Institute, for a special rate of $105.00, per night, single or double occupancy. For reservations, e-mail Amanda Major at and reference confirmation number 81257141 for the Clinical Oncology Review. Please reserve your hotel room no later than August 14, 2017 to ensure this special rate. 


Roswell Park Cancer Institute
Elm & Carlton Streets
Buffalo, NY, USA 14263


If you have any questions, contact Denise Hammell at or (716) 845-5706.